Drug that blocks DNA repair could improve survival for patients with one of the most aggressive prostate cancers

by ICO - Institut Català d'Oncologia

Patients with prostate cancer treated with a PARP inhibitor, called Rucaparib, take almost twice as long to progress the disease than those treated with chemotherapy conventional in tumors with BRCA m...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream